James J. Caruso - 05 Dec 2025 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Dec 2025, 16:54:19 UTC
Prior SEC filing
14 Aug 2025
Next SEC filing
30 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James J Caruso

Key filing fact

James J. Caruso filed Form 4 for Catheter Precision, Inc. (VTAK) on 08 Dec 2025.

Key facts

  • This page summarizes James J. Caruso's Form 4 filing for Catheter Precision, Inc. (VTAK).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Dec 2025, 16:54.

Change

  • Previous filing in this sequence was filed on 14 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001397215 Primary reporting owner

Caruso James Joseph

Relationship
Director
Address
1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL
Signature
/s/ James J Caruso
Signature date
08 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VTAK transaction

Common Stock

Conversion of derivative security

Transaction value
$0
Shares
+41
Change %
+456%
Price
$0.000000
Shares after
50
Date
05 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTAK transaction Derivative

Series X Convertible Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-8
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
0
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Series X Convertible Preferred Stock has no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .